Kalen Biomedical, LLC Signs Distribution Agreement With MRTeck Co.

Share Article

Kalen Biomedical, LLC (http://www.kalenbiomed.com) is pleased to announce a distribution agreement with MRTeck Co. in South Korea.

Kalen Biomedical

Kalen Biomedical

MRTeck has a well deserved reputation for serving the medical research community.

Kalen Biomedical, LLC has signed a distribution agreement with MRTeck Co. to offer premium lipoproteins to researchers in Korea. Kathy K. Foxx, President of Kalen Biomedical said, “We have a long relationship with MRTeck and are pleased to formalize it. Their reputation for serving the medical research community is well deserved.”

About Kalen Biomedical, LLC
Kalen Biomedical is a biotechnology company focused on the production of essential products for cardiovascular research. Kalen’s flagship lipoprotein product line is manufactured to exacting standards of quality using tested raw materials. Our products include native, oxidized, acetylated, and labeled human lipoproteins. The products are supported by Kalen’s expert research team and are backed by our performance guarantee. At Kalen Biomedical, we are committed to consistently providing you with products that will meet your research needs. We pride ourselves on being the partner of choice for cardiovascular research products.

About MRTeck, Co.

MRTeck Co. has provided the medical research community in South Korea with quality immunodiagnostic reagents for years. Their offerings include ELISA kits, enzymatic assays, chemical reagents, recombinant cytokines, peptides, proteins, antibodies, lipoproteins, and other laboratory supplies.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kathy Foxx
Visit website